Cargando…
A Cohort Study of Exposure to Antihyperglycemic Therapy and Survival in Patients with Lung Cancer
We evaluated the effect of antihyperglycemic therapy on the survival of patients with lung cancer (LC). The analysis included patients with LC and concomitant type 2 diabetes. 15,929 patients were classified into five groups: metformin users, insulin users, metformin and insulin users, sulphonylurea...
Autores principales: | Danila, Edvardas, Linkevičiūtė-Ulinskienė, Donata, Zablockis, Rolandas, Gruslys, Vygantas, Cicėnas, Saulius, Smailytė, Giedrė |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084663/ https://www.ncbi.nlm.nih.gov/pubmed/32156062 http://dx.doi.org/10.3390/ijerph17051747 |
Ejemplares similares
-
A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer
por: Dulskas, Audrius, et al.
Publicado: (2019) -
Cohort Study of Antihyperglycemic Medication and Pancreatic Cancer Patients Survival
por: Dulskas, Audrius, et al.
Publicado: (2020) -
A Cohort Study of Antihyperglycemic Medication Exposure and Gastric Cancer Risk
por: Dulskas, Audrius, et al.
Publicado: (2020) -
Case of Severe Treatment-Resistant Cryptogenic Organizing Pneumonia
por: Grigoravičius, Domas, et al.
Publicado: (2021) -
Lung Cancer Survival in Lithuania: Changes by Histology, Age, and Sex From 2003-2007 to 2008-2012
por: Gedvilaitė, Vaida, et al.
Publicado: (2019)